These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. [Human genetics in atypical hemolytic uremic syndrome-its role in diagnosis and treatment]. Knoop M, Haller H, Menne J. Internist (Berl); 2018 Aug; 59(8):799-804. PubMed ID: 29995248 [Abstract] [Full Text] [Related]
23. [Atypical hemolytic uremic syndrome]. Blasco Pelicano M, Rodríguez de Córdoba S, Campistol Plana JM. Med Clin (Barc); 2015 Nov 20; 145(10):438-45. PubMed ID: 25433773 [Abstract] [Full Text] [Related]
24. Atypical hemolytic uremic syndrome: a case report. Basnayake BMDB, Wazil AWM, Nanayakkara N, Samarakoon SMDK, Senavirathne EMSK, Thangarajah BUEWDR, Karunasena N, Mahanama RMBSS. J Med Case Rep; 2020 Jan 13; 14(1):11. PubMed ID: 31928535 [Abstract] [Full Text] [Related]
25. Diagnostic criteria for atypical hemolytic uremic syndrome proposed by the Joint Committee of the Japanese Society of Nephrology and the Japan Pediatric Society. Sawai T, Nangaku M, Ashida A, Fujimaru R, Hataya H, Hidaka Y, Kaname S, Okada H, Sato W, Yasuda T, Yoshida Y, Fujimura Y, Hattori M, Kagami S. Pediatr Int; 2014 Feb 13; 56(1):1-5. PubMed ID: 24548192 [Abstract] [Full Text] [Related]
26. Atypical hemolytic uremic syndrome in the setting of complement-amplifying conditions: case reports and a review of the evidence for treatment with eculizumab. Asif A, Nayer A, Haas CS. J Nephrol; 2017 Jun 13; 30(3):347-362. PubMed ID: 27848226 [Abstract] [Full Text] [Related]
27. [Atypical HUS caused by complement-related abnormalities]. Yoshida Y, Matsumoto M. Rinsho Ketsueki; 2015 Feb 13; 56(2):185-93. PubMed ID: 25765799 [Abstract] [Full Text] [Related]
28. Relapse of Atypical Hemolytic Uremic Syndrome During Pregnancy in a Patient on Eculizumab Maintenance Treatment: A Case Report. Fontana F, Alfano G, Bardhushi E, Ligabue G, Giovanella S, Neri I, Cappelli G. Am J Case Rep; 2019 Oct 04; 20():1460-1465. PubMed ID: 31582717 [Abstract] [Full Text] [Related]
29. Liver transplantation for aHUS: still needed in the eculizumab era? Coppo R, Bonaudo R, Peruzzi RL, Amore A, Brunati A, Romagnoli R, Salizzoni M, Galbusera M, Gotti E, Daina E, Noris M, Remuzzi G. Pediatr Nephrol; 2016 May 04; 31(5):759-68. PubMed ID: 26604087 [Abstract] [Full Text] [Related]
30. Atypical hemolytic uremic syndrome (aHUS): essential aspects of an accurate diagnosis. Laurence J, Haller H, Mannucci PM, Nangaku M, Praga M, Rodriguez de Cordoba S. Clin Adv Hematol Oncol; 2016 Nov 04; 14 Suppl 11(11):2-15. PubMed ID: 27930620 [Abstract] [Full Text] [Related]
31. Eculizumab Modifies Outcomes in Adults with Atypical Hemolytic Uremic Syndrome with Acute Kidney Injury. Cao M, Leite BN, Ferreiro T, Calvo M, Fernández C, Alonso Á, Rodriguez A, Salvador P, Seijo R, Pita S, Arjona E, Rodríguez de Córdoba S, Valdés Cañedo F. Am J Nephrol; 2018 Nov 04; 48(3):225-233. PubMed ID: 30205388 [Abstract] [Full Text] [Related]
32. Annual trends in atypical haemolytic uremic syndrome management in Japan and factors influencing early diagnosis and treatment: a retrospective study. Tatematsu Y, Imaizumi T, Michihata N, Kato N, Kumazawa R, Matsui H, Fushimi K, Yasunaga H, Maruyama S. Sci Rep; 2024 Aug 06; 14(1):18265. PubMed ID: 39107421 [Abstract] [Full Text] [Related]
33. Adult Post-Kidney Transplant Familial Atypical Hemolytic Uremic Syndrome Successfully Treated With Eculizumab: A Case Report and Literature Review. Salameh H, Abu Omar M, Alhariri A, Kisra S, Qasem A, Abdulhak AB. Am J Ther; 2016 Aug 06; 23(4):e1110-5. PubMed ID: 25486517 [Abstract] [Full Text] [Related]
34. [Atypical hemolytic uremic syndrome (aHUS): new insights into pathogenesis leading to novel therapeutic approaches]. Kistler AD. Praxis (Bern 1994); 2016 Mar 30; 105(7):389-96. PubMed ID: 27005733 [Abstract] [Full Text] [Related]
35. Eculizumab in anti-factor h antibodies associated with atypical hemolytic uremic syndrome. Diamante Chiodini B, Davin JC, Corazza F, Khaldi K, Dahan K, Ismaili K, Adams B. Pediatrics; 2014 Jun 30; 133(6):e1764-8. PubMed ID: 24843055 [Abstract] [Full Text] [Related]
36. [Atypical hemolytic uremic syndrome. Report of two cases treated with Eculizumab]. Tagle R, Rivera G, Walbaum B, Sepúlveda RA. Rev Med Chil; 2018 Feb 30; 146(2):254-259. PubMed ID: 29999163 [Abstract] [Full Text] [Related]
37. Renal recovery with eculizumab in atypical hemolytic uremic syndrome following prolonged dialysis. Povey H, Vundru R, Junglee N, Jibani M. Clin Nephrol; 2014 Nov 30; 82(5):326-31. PubMed ID: 23557793 [Abstract] [Full Text] [Related]
38. [Recurrent atypical hemolytic uremic syndrome after renal transplantation: treatment with eculizumab]. Latzke AB, Fernández P, Chiurchiu C, Sarmantano D, De Arteaga J, Douthat W, De la Fuente J. Medicina (B Aires); 2018 Nov 30; 78(2):119-122. PubMed ID: 29659362 [Abstract] [Full Text] [Related]
39. A retrospective study of pregnancy-associated atypical hemolytic uremic syndrome. Huerta A, Arjona E, Portoles J, Lopez-Sanchez P, Rabasco C, Espinosa M, Cavero T, Blasco M, Cao M, Manrique J, Cabello-Chavez V, Suñer M, Heras M, Fulladosa X, Belmar L, Sempere A, Peralta C, Castillo L, Arnau A, Praga M, Rodriguez de Cordoba S. Kidney Int; 2018 Feb 30; 93(2):450-459. PubMed ID: 28911789 [Abstract] [Full Text] [Related]
40. Efficacy and safety of eculizumab in adult patients with atypical hemolytic uremic syndrome: A single center experience from Turkey. Gediz F, Payzin BK, Ecemis S, Güler N, Yilmaz AF, Topcugil F, Berdeli A. Transfus Apher Sci; 2016 Dec 30; 55(3):357-362. PubMed ID: 27742267 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]